prostate cancer staging process physicians categorize risk cancer spread beyond prostate equivalently probability cured local therapies surgery radiation patients placed prognostic categories information contribute selection optimal approach treatment prostate cancer stage assessed either clinical pathological staging clinical staging usually occurs first treatment tumour presence determined imaging rectal examination pathological staging done treatment biopsy performed prostate removed looking cell types within two schemes commonly used stage prostate cancer united states common promulgated american joint committee cancer ajcc known tnm system evaluates size tumor extent involved lymph nodes metastasis distant spread also takes account cancer many cancers often grouped four stages another scheme used past whitmorejewett staging although tnm staging common modern united kingdom cambridge prognostic group cpg used replacing previous system divided prostate cancer three risk ajcc uicc stage disease cancer found incidentally small part sample prostate tissue removed reasons benign prostatic hypertrophy cells closely resemble normal cells gland feels normal examining finger stage ii prostate involved lump felt within gland stage iii tumor spread prostatic capsule lump felt surface gland stage iv disease tumor invaded nearby structures spread lymph nodes organs gleason grading system based cellular content tissue architecture biopsies provides estimate destructive potential ultimate prognosis disease stressed designation implies tumor palpable lobes prostate tumors found bilateral biopsy palpable bilaterally staged usually grade cancer different tissue normal tissue evaluated separately stage prostate cancer cell morphology graded based gleason grading systemcitation needed note system describing tumors well moderately poorly differentiated based gleason score respectively persists seer databases generally outdated recent years pathologists rarely assign tumor grade less particularly biopsy tissuecitation needed contemporary reporting standard includes grade prostate cancer grade group information prostatespecific antigen levels used conjunction tnm status group cases four overall needed ajcc staging system tumor lymph node metastasis gleason grade grouping prostatespecific antigen status combined four stages worsening although longer commonly used practice whitmorejewett system also known abcd rating similar tnm system approximately equivalent roman numerals sometimes used instead latin letters overall stages example stage stage stage ii stage b oncitation needed united kingdom nice guidelines recommend using cambridge prognostic group cpg categorising prostate cancer risk groups replaces older system used risk groups low medium high cpg score decided looking grade group gleason score prostate specific antigen psa level clinical tumor tnm staging important systems based anatomic features well suited deciding treatment best patient prostate cancer still considerable heterogeneity prognosis within stage categories refined prognosis established consideration prostatespecific antigen grade ie gleason score gleason grading system example common classify patients high intermediate lowrisk groups basis three factors tnm stage psa gleason score currently clear division stage historically statement anatomic extent disease diagnosis prognostic models may include many features contribute clinical outcomecitation needed treated patients lowrisk disease usually treated active surveillance prostatectomy radiotherapy alone patients intermediaterisk disease candidates prostatectomy radiotherapy short duration less months hormonal ablation medical castration using gonadotropinreleasing hormone analog although role surgery patients remains uncertain highrisk disease usually treated radiotherapy long duration hormonal ablation many highrisk patients cured treatment search better treatments group particularly pressing concern prostate cancer researchcitation needed httpsenwikipediaorgwikiprostatecancerstaging